Floatz logo

ETOPOSIDE

EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

University of WashingtonSmall moleculePhase 2/3Active
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
81/ 100

Competitive context

23 Active assets in the EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified cohort.

Asset / SponsorPhaseRating
Inno-206
University of Washington
Phase 2/3BB
PREDNISONE TABLETS
University of Washington
Phase 2/3BB
Cyclophosphamide
University of Washington
Phase 2/3BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
University of Washington
Phase 2/3BB
(+)-VINCRISTINE
Patrick C. Johnson, MD
Phase 2B

View all 30 →

Same molecule, other indications

ETOPOSIDE is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →